Nizhny Novgorod: NizhGMA development “biochip test system” is recognized as one of the best
Skolkovo development Nizhgma recognized one of the best innovations in the diagnosis and treatment of cancer.
According to the results of the competition “Skolkovo – Onkobiomed 2015” Innovative development of the scientists of the Nizhny Novgorod Medical Academy “biochip test systems” (project manager – oncologist Svyatoslav Zinoviev) is recognized as one of the best Russian projects in the development of innovative technologies of diagnosis and treatment of cancer.
Final OnkoBioMed-2105 will be held in the part of the XIX Congress of the Russian Cancer.
The best projects can obtain support for a variety of non-profit foundations, public development institutions, as well as leaders of the biomedical industry.
Test systems “biochip” are intended to define the immunophenotype of breast cancer cells, the origin of serous fluid, differential diagnosis of thyroid neoplasms, lung cancer, urogenital tract, search targets for drug therapy.
Biochips reduce the cost of the time spent in this laboratory study by 10 times, the reaction takes place in two stages instead of the current 30; reaction rate – about two hours instead of the traditional two days.
Press service NizhGMA
Link to original article:
